Advanced Search


Study ID Status Title Patient Level Data
112355 Completed A Randomized, Double-Blind, Parallel-Group, 16-Week Study to Evaluate the Effect of Fluticasone Propionate/Salmeterol DISKUS® 250/50mcg BID and Placebo on Arterial Stiffness in Subjects with Chronic Obstructive Pulmonary Disease (COPD) Study Listed on
112356 Completed A randomised, double-blind, placebo-controlled, 3-period cross-over study to evaluate the effect of two doses of GSK2190915 on the allergen-induced early asthmatic response in subjects with mild asthma Study Listed on
112359 Completed A single centre, randomised, double-blind, placebo-controlled, four-way cross over study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of GSK2190915 in healthy Japanese subjects. Study Listed on
112361 Withdrawn An open label, dose escalation study to examine the pharmacokinetics, pharmacodynamics and safety and tolerability of single and repeat oral doses of GSK2190915 in children aged from 1 to 11 years with asthma
112362 Completed An open label, sequential, single cohort, repeat dose study to investigate the potential interaction of GSK2190915 on the pharmacokinetics of rosuvastatin in healthy adult subjects. Study Listed on
112368 Completed Time trend analysis of diarrhea-related hospitalizations and deaths in children < 5 years of age in Brazil, 1990-2010
112376 Completed Study of salmeterol (SN408D) for adult asthma – Clinical study of salmeterol compared with Hokunalin (tulobuterol) tape –
112406 Completed Study of GSK2241658A Antigen-Specific Cancer Immunotherapeutic in patients with unresectable and Progressive Metastatic Cutaneous Melanoma
112437 Completed Osteoporosis: GPRD study - An assessment of GI associated adverse events associated with bisphophonates in the UK
112438 Completed A randomised, single-blind, placebo-controlled, study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single ascending administration of otelixizumab in subjects with Type 1 Diabetes Mellitus Study Listed on
112477 Relinquished An open label, multi-centre, non-interventional post-marketing surveillance (PMS) to monitor the safety and effectiveness of TYKERB® tablets administered in Korean patients according to the prescribing information
112480 Terminated A randomised, comparator controlled, two part, open-label study to evaluate the safety, tolerability and pharmacodynamics of multiple doses of otelixizumab in patients with thyroid orbitopathy Study Listed on
112483 Completed A single-centre, double-blind, placebo-controlled study to evaluate the safety, tolerabilty, pharmacokinetics, and pharmacodynamics of single, oral, ascending doses and repeat oral doses of GSK1325756 in healthy male subjects. Study Listed on
112485 Completed Safety of GlaxoSmithKline (GSK) Biologicals’ human papillomavirus (HPV)-16/18 vaccine, Cervarix® when administered to healthy females according to the prescribing information in Korea
112487 Terminated A randomised, double-blind, placebo controlled, parallel group , flexible dose study to evaluate the efficacy and safety of Paxil® Tablets in children and adolescents with Major Depressive Disorder<Post-marketing clinical study> Study Listed on
112509 Completed Study PMA112509, a Phase I/II Study of Eltrombopag in Thrombocytopenic Subjects with Advanced Myelodysplastic Syndrome (MDS) or secondary Acute Myeloid Leukemia after MDS (sAML/MDS)
112512 Withdrawn A Study of Single Dose Intravenous Casopitant in Combination with Ondansetron and Dexamethasone for the Prevention of Cisplatin-Induced Nausea and Vomiting
112515 Relinquished A Randomized, Phase III, Open-label Study of Lapatinib plus Trastuzumab versus Trastuzumab as Continued HER2 Suppression Therapy after Completion of First- or Second-line Trastuzumab plus Chemotherapy in Subjects with HER2-positive Metastatic Breast Cancer
112517 Relinquished A phase III, open label, randomized, multicenter trial of ofatumumab maintenance treatment versus no further treatment in subjects with relapsed chronic lymphocytic leukemia (CLL) who have responded to induction therapy
112529 Suspended A randomized, open label study comparing safety and efficacy parameters for a high and a low dose of ambrisentan (adjusted for body weight) for the treatment of pulmonary arterial hypertension in paediatric patients aged 8 years up to 18 years
112534 Completed A 2-Part trial: a randomized 6-day repeat-dose, parallel-group study in subjects with T2DM to assess the safety and tolerability of GSK1614235 compared to placebo and sitagliptin; and a randomized single-dose, food effect study in healthy volunteers to assess safety and tolerability of GSK1614235
112558 Completed A single dose and repeat dose study to investigate the pharmacokinetics of ropinirole after single and multiple doses of a PR-formulation in Chinese healthy male and female subjects
112560 Completed Epidemiological, observational, post marketing study of the genetic stability of GSK Biologicals’ rotavirus vaccine (Rotarix™) in children <5 years of age diagnosed with severe gastroenteritis, in Belgium
112564 Relinquished A Multicenter, Open-Label, Phase II Study of lapatinib in Combination with Vinorelbine in Subjects with ErbB2 Amplified Recurrent and Metastatic Breast Cancer
112565 Completed AMBITION: A Randomised, Multicenter Study of First-Line Ambrisentan and Tadalafil Combination Therapy in Subjects with Pulmonary Arterial Hypertension (PAH)



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.